Stifel Nicolaus Issues Positive Forecast for GE HealthCare Technologies (NASDAQ:GEHC) Stock Price

GE HealthCare Technologies (NASDAQ:GEHC) had its price objective boosted by Stifel Nicolaus from $90.00 to $95.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 9.43% from the company’s previous close.

GEHC has been the topic of a number of other reports. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Morgan Stanley increased their price objective on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Barclays initiated coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price target on the stock. Evercore ISI reissued an “outperform” rating and issued a $95.00 price target on shares of GE HealthCare Technologies in a research note on Monday. Finally, Citigroup lifted their price objective on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Seven equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $88.17.

GE HealthCare Technologies Trading Up 0.1%

Shares of GEHC stock opened at $86.81 on Wednesday. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $94.80. The stock’s fifty day simple moving average is $79.62 and its 200 day simple moving average is $76.41. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $39.54 billion, a P/E ratio of 17.90, a P/E/G ratio of 3.29 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same period last year, the firm posted $1.14 earnings per share. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

Institutional Trading of GE HealthCare Technologies

Several large investors have recently modified their holdings of GEHC. Glenview Trust co boosted its position in shares of GE HealthCare Technologies by 4.4% during the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock valued at $266,000 after buying an additional 139 shares during the period. True North Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 2.0% in the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after buying an additional 139 shares during the period. Klingman & Associates LLC lifted its stake in shares of GE HealthCare Technologies by 4.0% during the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock worth $273,000 after acquiring an additional 139 shares during the last quarter. Colonial Trust Advisors lifted its stake in shares of GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after acquiring an additional 139 shares during the last quarter. Finally, Silver Oak Securities Incorporated boosted its holdings in GE HealthCare Technologies by 4.6% during the 2nd quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock valued at $236,000 after acquiring an additional 140 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.